1HM Intrinsic Valuation and Fundamental Analysis - Adaptive Biotechnologies Corp

A	Adaptive Biotechnologies Corp F:1HM	US
	Outlook Therapeutics Inc F:41O	US

Intrinsic Value

The intrinsic value for Adaptive Biotechnologies Corp (1HM) under the Base Case is 4.871 EUR. Compared with the current market price of 19.525 EUR, the stock appears Overvalued by 75% .

Intrinsic value calculated using DCF

€4.871

Other reference points

Multiples estimate

€7.061

Wall St target

€55.226

Do our valuations actually work? See backtest results .

1HM Intrinsic Value

Overvaluation 75%

Intrinsic Value

Price €19.525

Track Buy Zone

20% below Intrinsic Value €3.9

Get notified when the price drops into your buy zone

Current Price €19.53

Intrinsic Value €4.87

Margin of Safety 20% €3.9

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Adaptive Biotechnologies Corp.

Explain Valuation